INFIQ — Infinity Pharmaceuticals Share News
0.000.00%
Last trade - 00:00IndustrialsHighly SpeculativeMicro Cap
- $0.00m
- -$17.75m
- $2.59m
Infinity Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Infinity Pharmaceuticals Reports Q1 2021 Financial Results And Provides Company Update
Brief: Infinity Pharmaceuticals Inc Files For Mixed Shelf Of Up To $250 Million – SEC Filing
Infinity Pharmaceuticals Inc expected to post a loss of 12 cents a share - Earnings Preview
Infinity Pharmaceuticals Inc expected to post a loss of 12 cents a share - Earnings Preview
Brief: Infinity Pharmaceuticals Expects Net Loss For 2021 To Range From $40 Mln To $50 Mln
Brief: Infinity Announces Pricing Of $80 Million Public Offering Of Common Stock
Brief: Infinity Announces Proposed Public Offering Of Common Stock
Infinity Pharmaceuticals: Rises on promising data from bladder cancer study
Brief: Infinity Pharmaceuticals Provides Update For Eganelisib In Patients With Metastatic Urothelial Cancer
Brief: Infinity Pharma Reports Data From Front-Line Triple Negative Breast Cancer Cohort From Ongoing Trial
Brief: Infinity Pharma Reports Q3 Loss Per Share Of $0.16
Brief: Infinity Pharmaceuticals Presents New Mario-1 Phase 1/1B Clinical Data At SITC
U.S. STOCKS ON THE MOVE-Caravana, Vroom, Peabody Energy, Canadian Solar
U.S. STOCKS ON THE MOVE-Scorpio Bulkers, LifeSci Acquisition, Shutterstock, Intellia Therapeutics
U.S. STOCKS ON THE MOVE-Infinity Pharmaceuticals, BioCardia, Caesars Entertainment, TransMedics Group
Infinity: Jumps on fast track tag for breast cancer treatment
Brief: Infinity Receives Fast Track Designation For Eganelisib In Combination With A Checkpoint Inhibitor And Chemotherapy For First-Line Treatment Of Advanced Tnbc
Brief: Infinity Pharmaceuticals- Co Received A Letter From Nasdaq Notifying That Company Had Regained Compliance